Catching up with Swati Abbott

BHIThought Leadership

Accountable Care News interviewed BHI’s CEO, Swati Abbott. Abbott has spent most of her career helping clients use data to improve healthcare. For the past 9 years, Abbott has overseen huge growth at BHI, since its spin-off from the national BlueCross BlueShield Association. In that time, BHI has become a leading independent provider of data analytics, software, and consulting for … Read More

Whyzen Boost Your Skills


In this Whyzen features webinar, Blue Health Intelligence® executives demonstrate some of the most powerful features of Whyzen Analytics – our account analytics and reporting solution for health plans, employers, and brokers. Whyzen’s state-of-the-art technology includes an advanced associative data model and embedded artificial intelligence. Its progressive machine-learning-enabled analytics become more accurate and actionable over time. This webinar dives deeply … Read More

Blue Health Intelligence’s CEO Reveals Claims Data Show True Impact of COVID-19, and How New Analytics Approaches Can Help Address Healthcare Challenges


CHICAGO (June 25, 2020) – Swati Abbott, CEO of Blue Health Intelligence® (BHI®), detailed the company’s wide-ranging efforts to help Blue Plans effectively respond to the challenges of COVID-19 in an address to the Blue Cross Blue Shield Association’s National Council of Physician and Pharmacist Executives (NCPE) meeting earlier today. She also discussed how BHI is taking a novel approach … Read More

Trends in Pregnancy and Childbirth Complications in the U.S.


Millions of women give birth in the U.S. every year. A majority of these women have healthy pregnancies and deliveries. However, an analysis of Blue Cross Blue Shield (BCBS) Association in collaboration with Blue Health Intelligence data reveals an increasing number of women are experiencing pregnancy complications and childbirth complications.

Concert Genetics, Blue Health Intelligence Partner on Effort to Set Data-Sharing Standards to Speed the Growth of Genetic Testing


NASHVILLE (June 10, 2020) – Concert Genetics, a company that seeks to standardize and digitize disparate data on genetic testing, has teamed with Blue Health Intelligence® (BHI®) to use BHI’s extensive U.S. commercial claims repository to refine tools that will fuel the growth of the genetic testing and precision medicine markets. Until recently, the ordering, collecting, storing, and billing of … Read More

BHI claims data is helping Concert Genetics connect a much-needed genetic health information network

BHICase Studies

Combining its genomic data with de-identified claims data from BHI has helped Concert Genetics shine a bright light on unnecessary coding variations and price disparities in the genetic health information network. The demand for genetic testing is dynamic and difficult for payers to discern. Using the BHI claims data along with their own data, Concert Genetics watches trends and helps … Read More

How Population Advyzer helped three health plans achieve significant ROI in risk adjustment

BHICase Studies

Population Advyzer was employed by three health plans to help improve their risk score accuracy and ensure reimbursement reflected the actual risks within their ACA and MA populations. Using the advanced analytics, predictive models, machine learning, and clinical logic within Population Advyzer, plans were able to uncover the most impactful opportunities to resolve coding discrepancies, close care gaps, and maximize … Read More